С М Носков

586 total citations
15 papers, 84 citations indexed

About

С М Носков is a scholar working on Cell Biology, Surgery and Rheumatology. According to data from OpenAlex, С М Носков has authored 15 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cell Biology, 4 papers in Surgery and 3 papers in Rheumatology. Recurrent topics in С М Носков's work include Myofascial pain diagnosis and treatment (5 papers), Shoulder Injury and Treatment (3 papers) and Platelet Disorders and Treatments (2 papers). С М Носков is often cited by papers focused on Myofascial pain diagnosis and treatment (5 papers), Shoulder Injury and Treatment (3 papers) and Platelet Disorders and Treatments (2 papers). С М Носков collaborates with scholars based in Russia and Austria. С М Носков's co-authors include J. Reinecke, Е. А. Таскина, С. А. Божкова, Л. И. Алексеева and А. М. Лила and has published in prestigious journals such as SHILAP Revista de lepidopterología, Osteoarthritis and Cartilage and Rejuvenation Research.

In The Last Decade

С М Носков

14 papers receiving 81 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
С М Носков Russia 5 37 20 20 17 15 15 84
Cevriye Mülkoğlu Türkiye 6 23 0.6× 24 1.2× 15 0.8× 19 1.1× 9 0.6× 25 106
Richard Evans United States 2 39 1.1× 31 1.6× 10 0.5× 6 0.4× 12 0.8× 3 76
Otto Zelger Germany 6 16 0.4× 33 1.6× 30 1.5× 7 0.4× 19 1.3× 10 218
Tommaso Bianchelli Italy 4 14 0.4× 10 0.5× 13 0.7× 5 0.3× 12 97
О. В. Бугрова Russia 6 90 2.4× 7 0.3× 9 0.5× 14 0.8× 4 0.3× 15 105
R. M. Berdondini Italy 9 26 0.7× 9 0.5× 3 0.1× 8 0.5× 2 0.1× 15 169
Haris Sheikh Pakistan 4 24 0.6× 23 1.1× 9 0.5× 3 0.2× 6 130
Erna V. Ivarsdottir Iceland 4 35 0.9× 14 0.7× 21 1.1× 14 0.8× 3 0.2× 4 90
Ana Carolina Handel Brazil 4 9 0.2× 19 0.9× 5 0.3× 6 0.4× 5 413
C. Mailhol France 7 54 1.5× 12 0.6× 11 0.6× 22 1.3× 2 0.1× 25 234

Countries citing papers authored by С М Носков

Since Specialization
Citations

This map shows the geographic impact of С М Носков's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by С М Носков with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites С М Носков more than expected).

Fields of papers citing papers by С М Носков

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by С М Носков. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by С М Носков. The network helps show where С М Носков may publish in the future.

Co-authorship network of co-authors of С М Носков

This figure shows the co-authorship network connecting the top 25 collaborators of С М Носков. A scholar is included among the top collaborators of С М Носков based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with С М Носков. С М Носков is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Носков, С М, et al.. (2023). A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers. Pharmacology Research & Perspectives. 11(5). e01125–e01125. 4 indexed citations
5.
Носков, С М, et al.. (2018). Platelet-rich plasma treatment in patients with osteoarthritis of the hip and greater trochanteric pain syndrome. Osteoarthritis and Cartilage. 26. S144–S144. 2 indexed citations
6.
Носков, С М, et al.. (2017). Comparison of clinical efficacy of platelet-rich plasma and autologous conditioned serum treatment in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage. 25. S438–S438. 11 indexed citations
7.
Носков, С М, et al.. (2015). Evaluation of the clinical efficacy of autologous conditioned serum in patients with coxarthrosis. Osteoarthritis and Cartilage. 23. A404–A404. 1 indexed citations
8.
Носков, С М, et al.. (2013). [Strategy for the use of chondroprotectors in osteoarthrosis].. PubMed. 85(5). 92–4. 1 indexed citations
9.
Носков, С М, et al.. (2012). Intestinal microbiocenosis in the obese patients with osteoarthritis. Problems of Endocrinology. 58(3). 12–15. 1 indexed citations
10.
Носков, С М, et al.. (2012). [Efficiency of use of autologous activated serum in coxarthrosis].. PubMed. 84(8). 33–6. 2 indexed citations
12.
Носков, С М, et al.. (2011). [Colonic microbial biocenosis in rheumatoid arthritis].. PubMed. 89(4). 45–8. 18 indexed citations
13.
Носков, С М, et al.. (2010). Local glucocorticoid therapy or low back pain. Neurology neuropsychiatry Psychosomatics. 0(4). 48–48. 2 indexed citations
14.
Носков, С М, et al.. (2005). [Alflutop in local therapy of shoulder periarthritis].. PubMed. 77(8). 57–60. 4 indexed citations
15.
Носков, С М. (1990). [Megaloblastic pancytopenia in a female patient with rheumatoid arthritis given methotrexate and amidopyrine simultaneously].. PubMed. 62(9). 122–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026